Crescita Therapeutics Stock Price, News & Analysis (TSE:CTX)

C$0.73 +0.09 (+14.06 %)
(As of 02/21/2018 04:00 PM ET)
Previous CloseC$0.64
Today's RangeC$0.66 - C$0.77
52-Week RangeC$0.50 - C$1.26
Volume67,740 shs
Average Volume33,015 shs
Market CapitalizationC$9.10 million
P/E Ratio-0.93
Dividend YieldN/A
BetaN/A

About Crescita Therapeutics (TSE:CTX)

Crescita Therapeutics Inc., a dermatology company, provides over-the-counter and prescription products for the treatment and care of skin diseases and their symptoms. It owns various proprietary drug delivery platforms, including DuraPeel and MMPE that support the development of patented formulations, which facilitate the delivery of active drugs into or through the skin. The company's prescription products include Pliaglis, a topical local anaesthetic cream that provides dermal analgesia on intact skin prior to superficial dermatological procedures; Mical 1 that is in Phase II stage for the treatment of psoriasis; and Mical 2, which is in preclinical stage for the dermatological skin treatment. Its non-prescription skincare products comprise skincare products for aging, acne, rosacea, pigmentation, dehydration, and sensitivity under the Laboratoire Dr Renaud brand; a line of cosmeceutical products for anti-aging medical procedures under the Pro-Derm brand; anti-aging skincare products to 35 years of age and over consumers under the Premiology brand; and a range of dermatology solutions under the ISDIN brand. The company also offers contract manufacturing services. It operates in Canada, Europe, the United States, and internationally. Crescita Therapeutics Inc. was incorporated in 2016 and is headquartered in Mississauga, Canada.

Receive CTX News and Ratings via Email

Sign-up to receive the latest news and ratings for CTX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
SymbolTSE:CTX
CUSIPN/A
Phone+1-905-6734295

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E Ratio-0.927536231884058
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPSC($0.69)
Net IncomeN/A
Net Margins-16.80%
Return on Equity-8.39%
Return on Assets-5.49%

Miscellaneous

EmployeesN/A
Outstanding Shares14,003,000

Crescita Therapeutics (TSE:CTX) Frequently Asked Questions

What is Crescita Therapeutics' stock symbol?

Crescita Therapeutics trades on the Toronto Stock Exchange (TSX) under the ticker symbol "CTX."

Who are some of Crescita Therapeutics' key competitors?

How do I buy Crescita Therapeutics stock?

Shares of Crescita Therapeutics and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

What is Crescita Therapeutics' stock price today?

One share of Crescita Therapeutics stock can currently be purchased for approximately C$0.73.

How big of a company is Crescita Therapeutics?

Crescita Therapeutics has a market capitalization of C$9.10 million.

How can I contact Crescita Therapeutics?

Crescita Therapeutics' mailing address is 7560 Airport Rd Unit 10, MISSISSAUGA, ON L4T 4H4, Canada. The company can be reached via phone at +1-905-6734295.


MarketBeat Community Rating for Crescita Therapeutics (CTX)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  20 (Vote Outperform)
Underperform Votes:  22 (Vote Underperform)
Total Votes:  42
MarketBeat's community ratings are surveys of what our community members think about Crescita Therapeutics and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Crescita Therapeutics (TSE:CTX) Analyst Ratings History


No equities research coverage for this company has been tracked by MarketBeat

Earnings

Earnings History for Crescita Therapeutics (TSE:CTX)


No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Crescita Therapeutics (TSE:CTX) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Crescita Therapeutics (TSE:CTX)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Crescita Therapeutics (TSE CTX) Insider Trading and Institutional Ownership History

Insider Trades by Quarter for Crescita Therapeutics (TSE:CTX)

Crescita Therapeutics (TSE CTX) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/5/2017Daniel ChicoineDirectorBuy86,200C$0.58C$49,996.00
12/5/2017Serge VerreaultInsiderBuy15,000C$0.55C$8,250.00
9/13/2017Yves BussiereInsiderBuy8,500C$0.58C$4,930.00
9/8/2017Anthony Edward DobranowskiDirectorBuy5,000C$0.61C$3,050.00
9/1/2017Yves BussiereInsiderBuy2,000C$0.64C$1,280.00
7/7/2017Daniel ChicoineDirectorBuy5,000C$0.62C$3,100.00
6/30/2017Daniel ChicoineDirectorBuy1,000C$0.75C$750.00
6/30/2017Serge VerreaultInsiderBuy2,000C$0.65C$1,300.00
6/29/2017Daniel ChicoineDirectorBuy5,000C$0.65C$3,250.00
(Data available from 1/1/2013 forward)

Headlines

Crescita Therapeutics (TSE CTX) News Headlines

Source:

SEC Filings

Crescita Therapeutics (TSE:CTX) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

Crescita Therapeutics (TSE CTX) Stock Chart for Wednesday, February, 21, 2018

Loading chart…

This page was last updated on 2/21/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.